ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
Holding ACAD?
Track your performance easily

ACADIA Pharmaceuticals (ACAD) Financial Statements

2,229 Followers

ACADIA Pharmaceuticals Financial Overview

ACADIA Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.178; its P/E ratio is 91.09; ACADIA Pharmaceuticals is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 241.96M$ 205.83M$ 231.04M$ 211.70M$ 165.24M
Gross Profit$ 223.73M$ 182.88M$ 213.15M$ 197.08M$ 157.78M
EBIT$ 37.19M$ 21.00M$ 34.94M$ -52.10M$ 6.30M
EBITDA$ 41.55M$ 24.74M$ 36.58M$ -52.37M$ 6.58M
Net Income Common Stockholders$ 33.38M$ 16.55M$ 45.80M$ -65.18M$ 1.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 572.47M$ 532.46M$ 474.68M$ 366.69M$ 384.58M
Total Assets$ 914.10M$ 855.10M$ 748.96M$ 632.54M$ 642.77M
Total Debt$ 47.19M$ 49.19M$ 47.80M$ 48.10M$ 49.78M
Net Debt$ -525.28M$ -483.27M$ -426.88M$ -318.58M$ -334.80M
Total Liabilities$ 397.40M$ 391.06M$ 317.20M$ 270.37M$ 246.98M
Stockholders Equity$ 516.70M$ 464.04M$ 431.75M$ 362.17M$ 395.79M
Cash Flow-
Free Cash Flow$ 25.01M$ 29.08M$ 85.39M$ -59.01M$ -31.80M
Operating Cash Flow$ 25.01M$ 29.08M$ 85.39M$ -58.95M$ 8.20M
Investing Cash Flow$ -56.19M$ -14.04M$ -347.00K$ 34.11M$ -194.28M
Financing Cash Flow$ 3.56M$ 1.04M$ 5.43M$ 12.75M$ 5.48M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

ACADIA Pharmaceuticals Debt to Assets

ACADIA Pharmaceuticals Cash Flow

ACADIA Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis